Gael Thomas

Gael Thomas has extensive work experience in the regulatory affairs field. Currently, they are serving as the Head of Regulatory Affairs - Global endocrinology at Recordati Rare Diseases Inc. Prior to this, they worked at ObsEva SA, where they held the positions of Vice-President Regulatory Affairs and Quality Management from January 2018 to February 2021, and Senior Director Regulatory Affairs from May 2013 to December 2017. Before ObsEva SA, Gael worked at Merck Serono as a Senior Regulatory Affairs Manager from April 2011 to March 2013 and as a Global Regulatory Affairs Manager from September 2008 to March 2011. At Galderma International, they served as a Regulatory Affairs Area Support Manager from October 2005 to July 2008. Gael began their career at Apotex Inc., where they worked as a Regulatory affairs project leader from March 2004 to September 2005, and as a regulatory affairs associate from September 2002 to February 2004.

Gael Thomas obtained a Doctor of Pharmacy (Pharm.D.) degree from Université de Bordeaux from 1995 to 2004. No specific field of study was mentioned.